Real-time enrollment status for this metastatic castration-resistant prostate adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:51 PM UTC
| NCT Number | NCT07698535 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-Resistant Prostate Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 64 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Washington |
| Last Updated on CT.gov | August 27, 2026 (Aug 27, 2026) |
As of October 12, 2026: Clinical trial NCT07698535 is currently recruiting participants. This phase2 study for metastatic castration-resistant prostate adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Washington. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07698535 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07698535 was last updated Aug 27, 2026 (August 27, 2026). HelloStudys verifies this status automatically.